© Reuters. Virtual press conference on the COVID-19 vaccination programme in London

LONDON (Reuters) – More data is needed to access the effectiveness of vaccines against the so-called Brazil variant of COVID-19, an British health official said on Monday.

“The current vaccines have not yet been studied against this variant, and we will need to wait for further clinical and trial data to understand the vaccine effectiveness against this variant,” Susan Hopkins from Public Health England told a news conference.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

READ  The G.O.P. Plot to Sabotage 2021

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here